With Sonalleve MR-HIFU, you can offer women with symptomatic uterine fibroids or adenomyotic tissue a therapy option that doesn’t exclude future pregnancy.* Patients usually go home the same day and return to their routines within two days.
You are about to visit a Philips global content page
ContinueYou are about to visit a Philips global content page
ContinueSelect country
Australia (English)
The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.